Doxepin hydrochloride 50 MG/ML Topical Cream [Zonalon] — RxCUI 1000095
RxNorm drug concept · Semantic branded drug
RxCUI 1000095
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1000095
Official nameDoxepin hydrochloride 50 MG/ML Topical Cream [Zonalon]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZonalon 5 % Topical Cream; Zonalon 50 MG/ML (doxepin 44.3 MG/ML) Topical Cream
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)75 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxepin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right that doxepin is also used as an antidepressant in pill form, but this cream version is completely different — it's applied to the skin specifically to relieve moderate...
- What exactly is this cream for? My doctor said it's for itching but it's usually an antidepressant — that seems strange.
- That's one of the most important things to know about this cream. Doxepin is absorbed through your skin into your bloodstream, and it can reach levels high enough to cause real dro...
- Why does the cream make me so sleepy? I didn't expect that from something I'm putting on my skin.
🕸️ Concept Web — How Doxepin hydrochloride 50 MG/ML Topical Cream [Zo... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxepin hydrochloride 50 MG/ML Topical Cream [Zonalon]
RxCUI 1000095 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Doxepin
3638IN -
Doxepin hydrochloride
203179PIN
-
Doxepin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zonalon
9801BN
-
Zonalon
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxepin Topical Cream
377691SCDF -
Doxepin hydrochloride Topical Cream
2647559SCDFP -
Doxepin Topical Product
1160770SCDG -
Doxepin hydrochloride Topical Product
2660570SCDGP -
Doxepin Topical Cream [Zonalon]
362333SBDF -
Doxepin hydrochloride Topical Cream [Zonalon]
2656146SBDFP -
Zonalon Topical Product
1188181SBDG -
Topical Cream
316982DF - +1 more in this family
-
Doxepin Topical Cream
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxepin hydrochloride 50 MG/ML Topical Cream
1000091SCD -
Doxepin hydrochloride 50 MG/ML
1000090SCDC -
Doxepin hydrochloride 50 MG/ML [Zonalon]
1000094SBDC
-
Doxepin hydrochloride 50 MG/ML Topical Cream
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxepin hydrochloride 50 MG/ML Topical Cream
SCD · 1000091 -
Doxepin hydrochloride 50 MG/ML
SCDC · 1000090 -
Doxepin Topical Cream
SCDF · 377691 -
Doxepin hydrochloride Topical Cream
SCDFP · 2647559 -
Doxepin Topical Product
SCDG · 1160770 -
Doxepin hydrochloride Topical Product
SCDGP · 2660570
Brand-Name Concepts
-
Doxepin hydrochloride 50 MG/ML [Zonalon]
SBDC · 1000094 -
Doxepin Topical Cream [Zonalon]
SBDF · 362333 -
Doxepin hydrochloride Topical Cream [Zonalon]
SBDFP · 2656146 -
Zonalon Topical Product
SBDG · 1188181 -
Zonalon
BN · 9801
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1000095 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-8123-30 | 1 TUBE in 1 CARTON (0378-8123-30) / 30 g in 1 TUBE | Zonalon | Mylan Pharmaceuticals Inc. | 2018-11-26 |
| 00378-8123-45 | 1 TUBE in 1 CARTON (0378-8123-45) / 45 g in 1 TUBE | Zonalon | Mylan Pharmaceuticals Inc. | 2018-11-14 |
Observed labelers:
Mylan Pharmaceuticals Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.